Nanjing Well Pharmaceutical Group Co.,Ltd. (603351.SS)
CNY 23.8
(0.68%)
CNY 23.8
(0.68%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 120.24 Million | 108.98 Million | -11.53 Million | 93.3 Million | 129.69 Million | 63.75 Million |
| Net Income | 109.11 Million | 94.43 Million | 100.14 Million | 100.44 Million | 128.1 Million | 111.81 Million |
| Depreciation & Amortization | 71.73 Million | 71.75 Million | 42.8 Million | 34.34 Million | 34.05 Million | 27.94 Million |
| Deferred income taxes | -3.71 Million | 147.31 Thousand | -15.43 Million | 504.6 Thousand | 8.5 Million | 2.81 Million |
| Stock-based compensation | 10.45 Million | 28.06 Million | 15.43 Million | - | - | - |
| Change in working capital | -88.47 Million | -94.89 Million | -180.52 Million | -38.95 Million | -36.44 Million | -82.51 Million |
| Other non-cash items | 14.67 Million | 9.48 Million | 26.03 Million | -2.53 Million | 3.96 Million | 6.51 Million |
| Investing Cash Flow | -67.84 Million | -237.67 Million | -67.96 Million | -165.43 Million | -495.69 Million | -76.43 Million |
| Investments in PPE | -73.07 Million | -233.9 Million | -235.62 Million | -282.43 Million | -120.61 Million | -76.94 Million |
| Acquisitions | 9.16 Million | 0.79 | 3.93 Million | -1.18 Billion | 84.85 Thousand | 4000.00 |
| Investment purchases | -1 Million | -35 Million | -45 Million | -40 Million | -40 Million | - |
| Sales/Maturities of investments | 6.22 Million | 31.22 Million | 217.72 Million | 1.18 Billion | 530.73 Million | - |
| Other Investing Activities | 5.22 Million | -3.77 Million | -8.99 Million | 157 Million | -865.89 Million | 517.79 Thousand |
| Financing Cash Flow | 4.79 Million | 161.19 Million | 70.56 Million | -32.6 Million | 508.9 Million | -24.63 Million |
| Debt repayment | -57.73 Million | -261.45 Million | -154.71 Million | -122.98 Million | -125.48 Million | -9.76 Million |
| Dividends payments | -37.93 Million | -40.64 Million | -39.2 Million | -42 Million | -40 Million | -30 Million |
| Common Stock Repurchased | - | - | -49.27 Million | - | - | - |
| Common Stock Issuance | - | - | 49.27 Million | - | - | -3.62 Million |
| Other Financing Activities | 475.74 Thousand | 474.53 Million | 270.52 Million | 137.46 Million | 679.28 Million | 5.36 Million |
| Accounts receivables | -31.41 Million | 34.16 Million | -105.72 Million | 71.33 Million | -34.79 Million | -67.72 Million |
| Accounts payables | -43.95 Million | -106.44 Million | -42.05 Million | -110.24 Million | 4.56 Million | -11.09 Million |
| Inventory | -9.38 Million | -22.76 Million | -29.17 Million | -551.85 Thousand | -14.71 Million | -6.51 Million |
| Other working capital | 10.45 Million | 147.31 Thousand | -3.56 Million | 504.6 Thousand | 8.5 Million | -75.99 Million |
| Cash at beginning of period | 99.82 Million | 66.26 Million | 75.55 Million | 180.93 Million | 37.58 Million | 75.28 Million |
| Cash at end of period | 157.54 Million | 99.82 Million | 66.26 Million | 75.55 Million | 180.93 Million | 37.58 Million |
| Capital Expenditure | -73.07 Million | -233.9 Million | -235.62 Million | -282.43 Million | -120.61 Million | -76.94 Million |
| Effect of forex changes on cash | 526.94 Thousand | 1.05 Million | -355 Thousand | -641 Thousand | 431.96 Thousand | -391.38 Thousand |
| Net cash flow / Change in cash | 57.71 Million | 33.56 Million | -9.29 Million | -105.37 Million | 143.34 Million | -37.69 Million |
| Free Cash Flow | 47.17 Million | -124.91 Million | -247.15 Million | -189.13 Million | 9.07 Million | -13.19 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 34 Million | 44.29 Million | 34.6 Million | 33.92 Million | 109.11 Million | 24.88 Million |
| Depreciation & Amortization | - | 25.87 Million | 25.87 Million | 17.84 Million | 71.73 Million | -36.28 Million |
| Deferred income taxes | - | - | - | - | -3.71 Million | -3.59 Million |
| Stock-based compensation | - | 2.82 Million | - | 10.45 Million | 10.45 Million | -7.16 Million |
| Change in working capital | - | -42.58 Million | - | -30.33 Million | -88.47 Million | 47.04 Million |
| Other non-cash items | 50.28 Million | 28.91 Million | -5.01 Million | 48.59 Million | 14.67 Million | 19.66 Million |
| Investing Cash Flow | -14.89 Million | -38.57 Million | -12.03 Million | -16.29 Million | -67.84 Million | -7.08 Million |
| Investments in PPE | -16 Million | -13.51 Million | -13.94 Million | -19.91 Million | -73.07 Million | -7.32 Million |
| Acquisitions | - | - | - | - | 9.16 Million | 955.53 Thousand |
| Investment purchases | -500 Thousand | -28.7 Million | - | - | -1 Million | - |
| Sales/Maturities of investments | 2.01 Million | 3.14 Million | 2.91 Million | 4.22 Million | 6.22 Million | - |
| Other Investing Activities | -400 Thousand | 500 Thousand | -1 Million | -603.86 Thousand | 5.22 Million | -719.12 Thousand |
| Financing Cash Flow | -72.74 Million | 17.55 Million | -28.83 Million | -63.74 Million | 4.79 Million | 18.18 Million |
| Debt repayment | -66.01 Million | -63.5 Million | -22.9 Million | -57.42 Million | -57.73 Million | -94.9 Million |
| Dividends payments | -3.38 Million | -44.62 Million | -2.81 Million | -37.93 Million | -37.93 Million | -37.93 Million |
| Common Stock Repurchased | - | - | - | -9.16 Million | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -3.34 Million | -45.94 Million | -3.11 Million | -1.96 Million | 475.74 Thousand | 116.44 Million |
| Accounts receivables | - | -46.27 Million | - | -31.41 Million | -31.41 Million | 31.49 Million |
| Accounts payables | - | - | - | - | -43.95 Million | 7.16 Million |
| Inventory | - | 860.16 Thousand | - | -9.38 Million | -9.38 Million | 15.55 Million |
| Other working capital | - | 2.82 Million | - | 10.45 Million | 10.45 Million | -7.16 Million |
| Cash at beginning of period | 173.21 Million | 146.93 Million | 157.54 Million | 173.25 Million | 99.82 Million | 117.44 Million |
| Cash at end of period | 169.86 Million | 173.21 Million | 146.93 Million | 157.54 Million | 157.54 Million | 173.25 Million |
| Capital Expenditure | -16 Million | -13.51 Million | -13.94 Million | -19.91 Million | -73.07 Million | -7.32 Million |
| Effect of forex changes on cash | 5507.32 | -36.29 Thousand | 667.16 Thousand | -341.4 Thousand | 526.94 Thousand | 164.44 Thousand |
| Net cash flow / Change in cash | -3.34 Million | 26.27 Million | -10.61 Million | -15.7 Million | 57.71 Million | 55.81 Million |
| Free Cash Flow | 68.27 Million | 33.81 Million | 15.63 Million | 44.76 Million | 47.17 Million | 37.22 Million |
3520
WNEB
4554
RDEXF
SE
0857